Literature DB >> 22366235

Chronic obstructive pulmonary disease: a slowly progressive cardiovascular disease masked by its pulmonary effects?

Frans H Rutten, Arno W Hoes.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22366235     DOI: 10.1093/eurjhf/hfs022

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  6 in total

Review 1.  β-Adrenoceptor modulation in chronic obstructive pulmonary disease: present and future perspectives.

Authors:  Maria Gabriella Matera; Luigino Calzetta; Mario Cazzola
Journal:  Drugs       Date:  2013-10       Impact factor: 9.546

Review 2.  Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases.

Authors:  Mario Cazzola; Luigino Calzetta; Barbara Rinaldi; Clive Page; Giuseppe Rosano; Paola Rogliani; Maria Gabriella Matera
Journal:  Drugs       Date:  2017-05       Impact factor: 9.546

Review 3.  Prevention of Exacerbations in Chronic Obstructive Pulmonary Disease: Knowns and Unknowns.

Authors:  Alvar Agustí; Peter M Calverley; Marc Decramer; Robert A Stockley; Jadwiga A Wedzicha
Journal:  Chronic Obstr Pulm Dis       Date:  2014-09-25

4.  Increased sympathetic nerve activity in COPD is associated with morbidity and mortality.

Authors:  Stefan Andreas; Helge Haarmann; Stephan Klarner; Gerd Hasenfuss; Tobias Raupach
Journal:  Lung       Date:  2013-12-22       Impact factor: 2.584

5.  CYP1B1, VEGFA, BCL2, and CDKN1A Affect the Development of Chronic Obstructive Pulmonary Disease.

Authors:  Danlei Yang; Ying Yan; Fen Hu; Tao Wang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-01-23

6.  Longitudinal change in lung function and subsequent risks of cardiovascular events: evidence from four prospective cohort studies.

Authors:  Yun-Jiu Cheng; Zhen-Guang Chen; Zhu-Yu Li; Wei-Yi Mei; Wen-Tao Bi; Dong-Ling Luo
Journal:  BMC Med       Date:  2021-07-02       Impact factor: 8.775

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.